Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement

Study Overview
=================
Brief Summary
-----------------
The purpose of this research is to understand how screening for patient resource needs followed by customized resource matching can improve outcomes for adults with breast, lung or gastrointestinal cancer.

Detailed Description
-----------------
This research study is an intervention assessment; this is the first-time investigators are examining the impact of screening for resource needs followed by customized resource matching at Dana-Farber Cancer Institute. The research study procedures include screening for social determinants of health (resource) needs and, depending on study group, resource matching. Participants will be randomized into one of two groups. Usual Care or Usual Care with customized resource matching. It is expected that about 125 participants will take part in this research study.

Official Title
-----------------
Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement

Conditions
-----------------
Breast Cancer, Lung Cancer, Gastrointestinal Cancer

Intervention / Treatment
-----------------
* Other: Resource Matching
* Other: Usual Care


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Eligible patients will be adults age 18 or older, able to consent, scheduled for a new patient consultation in DFCI BOC, TOP or GCC. To select for patients from demographic groups vulnerable to SDoH needs, two different groups will be eligible to participate. Group A BIPOC (Black, Latinx, Native American or Pacific Islander) LEP Spanish-speaking (As indicated by the EHR) Low SES (from zip code with median household income <$32,000/year) OR Age 70+ Group B Any one NPIQ response indicating SDoH need Health literacy/numeracy, Caregiving/relationships, OR Finances Exclusion Criteria: - Group A and B -- Patients not continuing care at Dana Farber Cancer Institute

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: RESOURCE Matching<br>Participants randomized into the intervention arm will receive customized resource matching | Other: Resource Matching<br>* Resource staff involved in the customized resource matching arm of the intervention will include staff from DFCI Patient Services and DFCI Financial Counseling. Financial counseling will support patients with financial resource needs. DFCI Patient Services will provide assistance for all other patient Social Determinants of Health needs.<br>|
| Active Comparator: Usual Care<br>Participants randomized into the control group will receive a pre-existing pamphlet detailing DFCI resources | Other: Usual Care<br>* Patients randomized to the control group will receive a pre-existing pamphlet detailing DFCI resources.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of Patients Treatment Interruption | Number of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record) | 30 Days | 
| Number of Patients Treatment Interruption | Number of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record) | 90 Days | 
| Number of Patients Treatment Interruption | Number of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record) | 180 Days | 
| Rate of Treatment Interruption | Rate of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record) | 00 Days | 
| Rate of Treatment Interruption | Rate of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record) | 90 Days | 
| Rate of Treatment Interruption | Rate of interruptions to cancer treatment (defined here as treatment hold, reduction, discontinuation or ED visits/hospitalizations as indicated by the patient medical record) | 180 Days | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Breast Cancer, Lung Cancer, Gastrointestinal Cancer